BLCO
USDBausch + Lomb Corporation Common Shares
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$15.470
Максимум
$15.554
Минимум
$15.300
Объем
0.81M
Фундаментальные показатели компании
Рыночная капитализация
5.5B
Отрасль
Medical Instruments & Supplies
Страна
Canada
Статистические данные торговли
Средний объем
0.52M
Биржа
NYQ
Валюта
USD
52-недельный диапазон
Связанные новости
Bausch + Lomb to Hold Investor Day on Nov. 13
Bausch + Lomb Corporation (NYSE/TSX:BLCO), a leading global eye health company dedicated to helping people see better to live better, will hold an investor day on Thursday, Nov. 13, 2025, at the New York Stock
Barclays Maintains Equal-Weight on Bausch & Lomb, Raises Price Target to $17
Barclays analyst Matt Miksic maintains Bausch & Lomb with a Equal-Weight and raises the price target from $16 to $17.
HC Wainwright & Co. Maintains Buy on Bausch & Lomb, Raises Price Target to $17
HC Wainwright & Co. analyst Yi Chen maintains Bausch & Lomb with a Buy and raises the price target from $16 to $17.
JP Morgan Maintains Neutral on Bausch & Lomb, Raises Price Target to $16
JP Morgan analyst Robbie Marcus maintains Bausch & Lomb with a Neutral and raises the price target from $13 to $16.
Evercore ISI Group Maintains Outperform on Bausch & Lomb, Raises Price Target to $18
Evercore ISI Group analyst Vijay Kumar maintains Bausch & Lomb with a Outperform and raises the price target from $17 to $18.
Wells Fargo Maintains Equal-Weight on Bausch & Lomb, Raises Price Target to $16
Wells Fargo analyst Larry Biegelsen maintains Bausch & Lomb with a Equal-Weight and raises the price target from $15 to $16.
Raymond James Reiterates Outperform on Bausch & Lomb, Raises Price Target to $19
Raymond James analyst Gary Nachman reiterates Bausch & Lomb with a Outperform and raises the price target from $18 to $19.
Связанные акции
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.